Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tyrosine Kinase Inhibitor-associated Cerebral Arterial Occlusive Disease Treated with High-flow Bypass Surgery: A Case Report. | NMC Case Rep J | 2023 | 37065876 | PubTator, text mining | PubMed |
| Identifying novel biomarkers associated with bladder cancer treatment outcomes. | Front Oncol | 2023 | 37064102 | PubTator, text mining | PubMed |
| A Systematic Review of Deep Learning Methodologies Used in the Drug Discovery Process with Emphasis on In Vivo Validation. | Int J Mol Sci | 2023 | 37047543 | PubTator, text mining | PubMed |
| Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. | Int J Mol Sci | 2023 | 37047231 | PubTator, text mining | PubMed |
| A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance. | Sci Rep | 2023 | 37031216 | PubTator, text mining | PubMed |
| MolFilterGAN: a progressively augmented generative adversarial network for triaging AI-designed molecules. | J Cheminform | 2023 | 37031191 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome. | PLoS One | 2023 | 37018234 | PubTator, text mining | PubMed |
A "Do No Harm" Novel Safety Checklist and Research Approach to Determine Whether to Launch an Artificial Intelligence-Based Medical Technology: Introducing the Biological-Psychological, Economic, and Social (BPES) Framework. | J Med Internet Res | 2023 | 37018019 | PubTator, text mining | PubMed |
| TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer. | Exp Mol Med | 2023 | 37009799 | PubTator, text mining | PubMed |
| Focusing on discoidin domain receptors in premalignant and malignant liver diseases. | Front Oncol | 2023 | 37007062 | PubTator, text mining | PubMed |
| Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report. | World J Surg Oncol | 2023 | 36998040 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps in tumor progression and immunotherapy. | Front Immunol | 2023 | 36993957 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors in HBV-Caused Hepatocellular Carcinoma Therapy. | Vaccines (Basel) | 2023 | 36992198 | PubTator, text mining | PubMed |
| Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery. | Pharmaceuticals (Basel) | 2023 | 36986432 | PubTator, text mining | PubMed |
| Drug-Induced Gingival Overgrowth-Molecular Aspects of Drug Actions. | Int J Mol Sci | 2023 | 36982523 | PubTator, text mining | PubMed |
| A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives. | Cells | 2023 | 36980246 | PubTator, text mining | PubMed |
| Deep generative model for drug design from protein target sequence. | J Cheminform | 2023 | 36978179 | PubTator, text mining | PubMed |
| From Minerals to Simplest Living Matter: Life Origination Hydrate Theory. | Acta Biotheor | 2023 | 36976380 | PubTator, text mining | PubMed |
| Biomimetic Remineralized Three-Dimensional Collagen Bone Matrices with an Enhanced Osteostimulating Effect. | Biomimetics (Basel) | 2023 | 36975321 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=20